MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$26,609,695
(-243.99%↓ Y/Y)
Income tax expense
(benefit)
-$231,210
(-187.50%↓ Y/Y)
Gain on sale of new
jersey net operating...
$1,762,000
Interest income
$43,721
Gross product revenue
$2,003,760
Loss before income
taxes
-$26,840,905
(-259.25%↓ Y/Y)
Total other income,
net
$1,772,690
Revenues
$1,667,298
Interest expense
$33,031
Gross-to-net adjustments
$336,462
Operating loss
-$28,613,595
Gross profit
$1,338,420
Cost of revenues
$328,878
Total operating
expenses
$29,952,015
(300.89%↑ Y/Y)
General and
administrative
$23,625,639
(953.15%↑ Y/Y)
Stock-based compensation
general and...
$3,526,710
(68.86%↑ Y/Y)
Amortization of in-process
research and development
$1,720,312
Research and development
$1,079,354
(-65.62%↓ Y/Y)
Back
Back
Income Statement
CITIUS ONCOLOGY, INC. (CTOR)
CITIUS ONCOLOGY, INC. (CTOR)
source: myfinsight.com